Apollon Wealth Management LLC Acquires 352 Shares of Waters Corporation $WAT

Apollon Wealth Management LLC raised its holdings in shares of Waters Corporation (NYSE:WAT) by 10.3% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 3,755 shares of the medical instruments supplier’s stock after acquiring an additional 352 shares during the period. Apollon Wealth Management LLC’s holdings in Waters were worth $1,311,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also bought and sold shares of WAT. Brighton Jones LLC grew its position in Waters by 112.9% during the fourth quarter. Brighton Jones LLC now owns 1,269 shares of the medical instruments supplier’s stock valued at $471,000 after acquiring an additional 673 shares during the last quarter. GAMMA Investing LLC boosted its holdings in Waters by 36.6% during the 1st quarter. GAMMA Investing LLC now owns 1,797 shares of the medical instruments supplier’s stock valued at $662,000 after acquiring an additional 481 shares during the period. CX Institutional purchased a new stake in Waters during the 1st quarter valued at about $75,000. Fifth Third Bancorp boosted its holdings in Waters by 2.3% during the 1st quarter. Fifth Third Bancorp now owns 2,273 shares of the medical instruments supplier’s stock valued at $838,000 after acquiring an additional 52 shares during the period. Finally, Wealth Enhancement Advisory Services LLC boosted its holdings in Waters by 169.1% during the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 11,619 shares of the medical instruments supplier’s stock valued at $4,283,000 after acquiring an additional 7,301 shares during the period. 94.01% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

WAT has been the subject of several analyst reports. Redburn Partners set a $390.00 target price on Waters in a report on Wednesday, October 8th. Deutsche Bank Aktiengesellschaft set a $315.00 target price on Waters and gave the company a “hold” rating in a report on Tuesday, August 5th. Bank of America increased their target price on Waters from $370.00 to $375.00 and gave the company a “neutral” rating in a report on Thursday, June 26th. Wells Fargo & Company dropped their target price on Waters from $330.00 to $315.00 and set an “equal weight” rating for the company in a report on Tuesday, August 5th. Finally, UBS Group reiterated a “neutral” rating on shares of Waters in a report on Tuesday, July 15th. Two investment analysts have rated the stock with a Strong Buy rating, six have assigned a Buy rating and nine have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, Waters has a consensus rating of “Moderate Buy” and a consensus price target of $377.56.

Waters Trading Down 0.9%

NYSE WAT opened at $333.45 on Wednesday. Waters Corporation has a fifty-two week low of $275.05 and a fifty-two week high of $423.56. The company has a debt-to-equity ratio of 0.55, a quick ratio of 1.22 and a current ratio of 1.75. The stock has a 50 day simple moving average of $302.03 and a two-hundred day simple moving average of $323.46. The stock has a market cap of $19.85 billion, a P/E ratio of 30.07, a price-to-earnings-growth ratio of 3.14 and a beta of 1.04.

Waters (NYSE:WAT) last announced its earnings results on Thursday, May 19th. The medical instruments supplier reported $2.29 earnings per share (EPS) for the quarter. Waters had a return on equity of 38.60% and a net margin of 21.71%.The firm had revenue of $608.55 million during the quarter. On average, analysts forecast that Waters Corporation will post 12.86 earnings per share for the current year.

About Waters

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.